Journal of Clinical Epidemiology
Volume 49, Issue 2 , Pages 247-250 , February 1996

Salmeterol: A study by Prescription Event Monitoring in a UK cohort of 15,407 patients

,Revised 23 June 1995

References 

  1. Mann RD. Epidemiologic study systems: Prescription-Event Monitoring in the UK. Southampton Med J. 1994;10:12–17
  2. Inman WHW, Kubota K, Wilton LV, Pearce GL. PEM Report No. 1. Nicardipine. Pharmacoepidemiol Drug Safety. 1993;2:259–285
  3. Inman WHW, Clarke J, Wilton LV, Pearce GL, Veldhuis G. PEM Report No. 2. Terodiline. Pharmacoepidemiol Drug Safety. 1993;2:287–319
  4. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 3. Fluconazole. Pharmacoepidemiol Drug Safety. 1993;2:321–340
  5. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 4. Ciprofloxacin. Pharmacoepidemiol Drug Safety. 1993;2:341–364
  6. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 5. Fluoxetine. Pharmacoepidemiol Drug Safety. 1993;2:365–391
  7. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 6. Paroxetine. Pharmacoepidemiol Drug Safety. 1993;2:393–422
  8. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 7. Itraconazole. Pharmacoepidemiol Drug Safety. 1993;2:423–443
  9. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 8. Cisapride. Pharmacoepidemiol Drug Safety. 1993;2:445–471
  10. Wilton LV, Inman WHW, Kubota K, Pearce GL, Skipp M. PEM Report No. 9. Omeprazole. Pharmacoepidemiol Drug Safety. 1993;2:473–498
  11. Inman WHW, Kubota K, Pearce GL, Wilton LV. PEM Report No. 10. Zopiclone. Pharmacoepidemiol Drug Safety. 1993;2:499–521
  12. Inman WHW, Rawson NSB, Wilton LV, Pearce GL, Speirs CJ. Post-marketing surveillance of enalapril. I: Results of prescription-event monitoring. Br Med J. 1988;297:826–829
  13. Rawson NSB. An acute adverse drug reaction alerting scheme using the Saskatchewan health datafiles. Drug Invest. 1993;6(5):245–256
  14. Kubota K, Kubota N, Pearce G, Prescott P, Mann RD. Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event Monitoring. Int J Clin Pharmacol Ther. 1995;33(4):219–225
  15. Castle WM, Fuller RW, Hal JR, Palmer JBD. Serevent nationwide surveillance study: Comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. Br Med J. 1993;306:1034–1037
  16. Bunney R. Study too small to detect increase in deaths (letter). Br Med J. 1993;306:1610

☆ A more extensive report of this stud is available, for the cost of photocopying, from the Drug Safety Research Unit, SoutLmpton, SO31 JAA, U.K.

PII: 0895-4356(95)00555-2

Journal of Clinical Epidemiology
Volume 49, Issue 2 , Pages 247-250 , February 1996

Article Tools